(AEGR) (GEVA) (MACK) (SUPN) (XOMA) (ZGNX) to be Added to NASDAQ Biotechnology Index (IBB)

November 12, 2012 8:09 AM EST
The NASDAQ OMX Group announced that Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), Synageva BioPharma Corp. (Nasdaq: GEVA), Merrimack Pharmaceuticals, Inc.(Nasdaq: MACK), Supernus Pharmaceuticals, Inc.(Nasdaq: SUPN), XOMA Corporation (Nasdaq: XOMA) and Zogenix, Inc. (Nasdaq: ZGNX) will be added to NASDAQ Biotechnology Index effective prior to market open on Monday, November 19, 2012.

Maxygen, Inc. (Nasdaq: MAXY) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) will be removed from the index.

Related ETF: iShares Nasdaq Biotechnology (NASDAQ: IBB).

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

ETFs, Trader Talk

Add Your Comment